Background and Aims: Gastrointestinal (GI) bleeding has been observed among patients
hospitalized with COVID-19. Recently anticoagulation has shown to decrease mortality, but it is
unclear if this contributes to increased GI bleeding.
The aims of this study are: 1) to examine if there are risk factors for GI bleeding in COVID-19
patients 2) to study whether there is a mortality difference between hospitalized patients with COVID-
19 with and without GI bleeding.
Methods: This is a propensity score matched case-control study from a large health system in the
New York metropolitan area between March 1
st
and April 27
th
.
Do'stlaringiz bilan baham: |